An aggregate measure of sleep health is associated with prevalent and incident clinically significant depression symptoms among community-dwelling older women R Furihata, MH Hall, KL Stone, S Ancoli-Israel, SF Smagula, JA Cauley, ... Sleep 40 (3), zsw075, 2017 | 113 | 2017 |
The association between sleep problems and perceived health status: a Japanese nationwide general population survey R Furihata, M Uchiyama, S Takahashi, M Suzuki, C Konno, K Osaki, ... Sleep medicine 13 (7), 831-837, 2012 | 107 | 2012 |
Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain–gut axis K Takahashi, O Nakagawasai, W Nemoto, T Odaira, W Sakuma, H Onogi, ... Journal of Neuroinflammation 16, 1-16, 2019 | 82 | 2019 |
Seasonal changes in sleep duration and sleep problems: A prospective study in Japanese community residents M Suzuki, T Taniguchi, R Furihata, K Yoshita, Y Arai, N Yoshiike, ... PLoS One 14 (4), e0215345, 2019 | 71 | 2019 |
Stressful events and coping strategies associated with symptoms of depression: a Japanese general population survey M Suzuki, R Furihata, C Konno, Y Kaneita, T Ohida, M Uchiyama Journal of Affective Disorders 238, 482-488, 2018 | 56 | 2018 |
Association of short sleep duration and short time in bed with depression: A Japanese general population survey R Furihata, M Uchiyama, M Suzuki, C Konno, M Konno, S Takahashi, ... Sleep and Biological Rhythms 13, 136-145, 2015 | 55 | 2015 |
Unhealthy lifestyle factors and depressive symptoms: A Japanese general adult population survey R Furihata, C Konno, M Suzuki, S Takahashi, Y Kaneita, T Ohida, ... Journal of affective disorders 234, 156-161, 2018 | 48 | 2018 |
Napping and associated factors: a Japanese nationwide general population survey R Furihata, Y Kaneita, M Jike, T Ohida, M Uchiyama Sleep medicine 20, 72-79, 2016 | 46 | 2016 |
A composite measure of sleep health is associated with symptoms of depression among Japanese female hospital nurses R Furihata, K Saitoh, M Suzuki, M Jike, Y Kaneita, T Ohida, DJ Buysse, ... Comprehensive psychiatry 97, 152151, 2020 | 44 | 2020 |
Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for … Y Takaesu, K Watanabe, S Numata, M Iwata, N Kudo, S Oishi, T Takizawa, ... Psychiatry and clinical neurosciences 73 (10), 642-648, 2019 | 43 | 2019 |
Prescription patterns in patients with schizophrenia in Japan: first‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in … K Ichihashi, H Hori, N Hasegawa, Y Yasuda, T Yamamoto, T Tsuboi, ... Neuropsychopharmacology reports 40 (3), 281-286, 2020 | 35 | 2020 |
Self-help behaviors for sleep and depression: a Japanese nationwide general population survey R Furihata, M Uchiyama, S Takahashi, C Konno, M Suzuki, K Osaki, ... Journal of affective disorders 130 (1-2), 75-82, 2011 | 34 | 2011 |
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for … N Hashimoto, N Yasui-Furukori, N Hasegawa, S Ishikawa, S Numata, ... Asian Journal of Psychiatry 63, 102744, 2021 | 32 | 2021 |
Association between reduced serum BDNF levels and insomnia with short sleep duration among female hospital nurses R Furihata, K Saitoh, R Otsuki, S Murata, M Suzuki, M Jike, Y Kaneita, ... Sleep medicine 68, 167-172, 2020 | 28 | 2020 |
Unmet needs of patients with major depressive disorder–Findings from the ‘E ffectiveness of G uidelines for D issemination and E ducation in P sychiatric T reatment (EGUIDE … H Iida, J Iga, N Hasegawa, Y Yasuda, T Yamamoto, K Miura, J Matsumoto, ... Psychiatry and clinical neurosciences 74 (12), 667-669, 2020 | 26 | 2020 |
Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study N Yasui‐Furukori, H Muraoka, N Hasegawa, S Ochi, S Numata, H Hori, ... Neuropsychopharmacology reports 42 (1), 3-9, 2022 | 21 | 2022 |
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study S Numata, M Nakataki, N Hasegawa, Y Takaesu, M Takeshima, ... Neuropsychopharmacology Reports 41 (2), 199-206, 2021 | 19 | 2021 |
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study R Furihata, R Otsuki, N Hasegawa, T Tsuboi, S Numata, N Yasui-Furukori, ... Sleep Medicine 89, 23-30, 2022 | 18 | 2022 |
Association of serum BDNF levels and the BDNF Val66Met polymorphism with the sleep pattern in healthy young adults K Saitoh, R Furihata, Y Kaneko, M Suzuki, S Takahashi, M Uchiyama PLoS One 13 (6), e0199765, 2018 | 18 | 2018 |
Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: a real-world … S Ochi, H Tagata, N Hasegawa, N Yasui-Furukori, J Iga, H Kashiwagi, ... International Journal of Neuropsychopharmacology 25 (10), 818-826, 2022 | 17 | 2022 |